Industry: Medical Devices & Consumables
Published Date: 2024-01-12
Pages: 91 Pages
Report ld: 2725096
Request Sample
Customized Report
Automatic Peptide Continuous Synthesizer Market Size(US$)

CAGR 2024-2030
2.6%
Market Size,2030
USD 88
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Automatic Peptide Continuous Synthesizer market was valued at US$ 73 million in 2023 and is anticipated to reach US$ 88 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
North American market for Automatic Peptide Continuous Synthesizer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Automatic Peptide Continuous Synthesizer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Automatic Peptide Continuous Synthesizer include Gyros Protein Technologies AB, Büchi AG, Biotage, CEM, CSBio, AAPPTec, Activotec, MultiSynTech and NJ Biopharmaceuticals LLC, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Automatic Peptide Continuous Synthesizer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Peptide Continuous Synthesizer.
MARKET SEGMENTATION
REPORT SCOPE
The Automatic Peptide Continuous Synthesizer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automatic Peptide Continuous Synthesizer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automatic Peptide Continuous Synthesizer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automatic Peptide Continuous Synthesizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automatic Peptide Continuous Synthesizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Automatic Peptide Continuous Synthesizer Market Overview
1.1 Product Overview and Scope of Automatic Peptide Continuous Synthesizer
1.2 Automatic Peptide Continuous Synthesizer Segment by Type
1.2.1 Global Automatic Peptide Continuous Synthesizer Market Value Comparison by Type (2024-2030)
1.2.2 Fully Automatic
1.2.3 Aemi-automatic
1.2.4 Manual
1.3 Automatic Peptide Continuous Synthesizer Segment by Application
1.3.1 Global Automatic Peptide Continuous Synthesizer Market Value by Application: (2024-2030)
1.3.2 Laboratory
1.3.3 University
1.3.4 Research Center
1.4 Global Automatic Peptide Continuous Synthesizer Market Size Estimates and Forecasts
1.4.1 Global Automatic Peptide Continuous Synthesizer Revenue 2019-2030
1.4.2 Global Automatic Peptide Continuous Synthesizer Sales 2019-2030
1.4.3 Global Automatic Peptide Continuous Synthesizer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Automatic Peptide Continuous Synthesizer Market Competition by Manufacturers
2.1 Global Automatic Peptide Continuous Synthesizer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Automatic Peptide Continuous Synthesizer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Automatic Peptide Continuous Synthesizer Average Price by Manufacturers (2019-2024)
2.4 Global Automatic Peptide Continuous Synthesizer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Automatic Peptide Continuous Synthesizer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automatic Peptide Continuous Synthesizer, Product Type & Application
2.7 Automatic Peptide Continuous Synthesizer Market Competitive Situation and Trends
2.7.1 Automatic Peptide Continuous Synthesizer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automatic Peptide Continuous Synthesizer Players Market Share by Revenue
2.7.3 Global Automatic Peptide Continuous Synthesizer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automatic Peptide Continuous Synthesizer Retrospective Market Scenario by Region
3.1 Global Automatic Peptide Continuous Synthesizer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Automatic Peptide Continuous Synthesizer Global Automatic Peptide Continuous Synthesizer Sales by Region: 2019-2030
3.2.1 Global Automatic Peptide Continuous Synthesizer Sales by Region: 2019-2024
3.2.2 Global Automatic Peptide Continuous Synthesizer Sales by Region: 2025-2030
3.3 Global Automatic Peptide Continuous Synthesizer Global Automatic Peptide Continuous Synthesizer Revenue by Region: 2019-2030
3.3.1 Global Automatic Peptide Continuous Synthesizer Revenue by Region: 2019-2024
3.3.2 Global Automatic Peptide Continuous Synthesizer Revenue by Region: 2025-2030
3.4 North America Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.4.1 North America Automatic Peptide Continuous Synthesizer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Automatic Peptide Continuous Synthesizer Sales by Country (2019-2030)
3.4.3 North America Automatic Peptide Continuous Synthesizer Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.5.1 Europe Automatic Peptide Continuous Synthesizer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Automatic Peptide Continuous Synthesizer Sales by Country (2019-2030)
3.5.3 Europe Automatic Peptide Continuous Synthesizer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.6.1 Asia Pacific Automatic Peptide Continuous Synthesizer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Automatic Peptide Continuous Synthesizer Sales by Country (2019-2030)
3.6.3 Asia Pacific Automatic Peptide Continuous Synthesizer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.7.1 Latin America Automatic Peptide Continuous Synthesizer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Automatic Peptide Continuous Synthesizer Sales by Country (2019-2030)
3.7.3 Latin America Automatic Peptide Continuous Synthesizer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automatic Peptide Continuous Synthesizer Market Facts & Figures by Country
3.8.1 Middle East and Africa Automatic Peptide Continuous Synthesizer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Automatic Peptide Continuous Synthesizer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Automatic Peptide Continuous Synthesizer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automatic Peptide Continuous Synthesizer Sales by Type (2019-2030)
4.1.1 Global Automatic Peptide Continuous Synthesizer Sales by Type (2019-2024)
4.1.2 Global Automatic Peptide Continuous Synthesizer Sales by Type (2025-2030)
4.1.3 Global Automatic Peptide Continuous Synthesizer Sales Market Share by Type (2019-2030)
4.2 Global Automatic Peptide Continuous Synthesizer Revenue by Type (2019-2030)
4.2.1 Global Automatic Peptide Continuous Synthesizer Revenue by Type (2019-2024)
4.2.2 Global Automatic Peptide Continuous Synthesizer Revenue by Type (2025-2030)
4.2.3 Global Automatic Peptide Continuous Synthesizer Revenue Market Share by Type (2019-2030)
4.3 Global Automatic Peptide Continuous Synthesizer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Automatic Peptide Continuous Synthesizer Sales by Application (2019-2030)
5.1.1 Global Automatic Peptide Continuous Synthesizer Sales by Application (2019-2024)
5.1.2 Global Automatic Peptide Continuous Synthesizer Sales by Application (2025-2030)
5.1.3 Global Automatic Peptide Continuous Synthesizer Sales Market Share by Application (2019-2030)
5.2 Global Automatic Peptide Continuous Synthesizer Revenue by Application (2019-2030)
5.2.1 Global Automatic Peptide Continuous Synthesizer Revenue by Application (2019-2024)
5.2.2 Global Automatic Peptide Continuous Synthesizer Revenue by Application (2025-2030)
5.2.3 Global Automatic Peptide Continuous Synthesizer Revenue Market Share by Application (2019-2030)
5.3 Global Automatic Peptide Continuous Synthesizer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gyros Protein Technologies AB
6.1.1 Gyros Protein Technologies AB Corporation Information
6.1.2 Gyros Protein Technologies AB Description and Business Overview
6.1.3 Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Product Portfolio
6.1.5 Gyros Protein Technologies AB Recent Developments/Updates
6.2 Büchi AG
6.2.1 Büchi AG Corporation Information
6.2.2 Büchi AG Description and Business Overview
6.2.3 Büchi AG Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Büchi AG Automatic Peptide Continuous Synthesizer Product Portfolio
6.2.5 Büchi AG Recent Developments/Updates
6.3 Biotage
6.3.1 Biotage Corporation Information
6.3.2 Biotage Description and Business Overview
6.3.3 Biotage Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biotage Automatic Peptide Continuous Synthesizer Product Portfolio
6.3.5 Biotage Recent Developments/Updates
6.4 CEM
6.4.1 CEM Corporation Information
6.4.2 CEM Description and Business Overview
6.4.3 CEM Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CEM Automatic Peptide Continuous Synthesizer Product Portfolio
6.4.5 CEM Recent Developments/Updates
6.5 CSBio
6.5.1 CSBio Corporation Information
6.5.2 CSBio Description and Business Overview
6.5.3 CSBio Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CSBio Automatic Peptide Continuous Synthesizer Product Portfolio
6.5.5 CSBio Recent Developments/Updates
6.6 AAPPTec
6.6.1 AAPPTec Corporation Information
6.6.2 AAPPTec Description and Business Overview
6.6.3 AAPPTec Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AAPPTec Automatic Peptide Continuous Synthesizer Product Portfolio
6.6.5 AAPPTec Recent Developments/Updates
6.7 Activotec
6.6.1 Activotec Corporation Information
6.6.2 Activotec Description and Business Overview
6.6.3 Activotec Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Activotec Automatic Peptide Continuous Synthesizer Product Portfolio
6.7.5 Activotec Recent Developments/Updates
6.8 MultiSynTech
6.8.1 MultiSynTech Corporation Information
6.8.2 MultiSynTech Description and Business Overview
6.8.3 MultiSynTech Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MultiSynTech Automatic Peptide Continuous Synthesizer Product Portfolio
6.8.5 MultiSynTech Recent Developments/Updates
6.9 NJ Biopharmaceuticals LLC
6.9.1 NJ Biopharmaceuticals LLC Corporation Information
6.9.2 NJ Biopharmaceuticals LLC Description and Business Overview
6.9.3 NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.9.4 NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Product Portfolio
6.9.5 NJ Biopharmaceuticals LLC Recent Developments/Updates
6.10 Peptide Machines, Inc.
6.10.1 Peptide Machines, Inc. Corporation Information
6.10.2 Peptide Machines, Inc. Description and Business Overview
6.10.3 Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Product Portfolio
6.10.5 Peptide Machines, Inc. Recent Developments/Updates
6.11 Protein Technologies, Inc.
6.11.1 Protein Technologies, Inc. Corporation Information
6.11.2 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Description and Business Overview
6.11.3 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Product Portfolio
6.11.5 Protein Technologies, Inc. Recent Developments/Updates
6.12 Intavis AG
6.12.1 Intavis AG Corporation Information
6.12.2 Intavis AG Automatic Peptide Continuous Synthesizer Description and Business Overview
6.12.3 Intavis AG Automatic Peptide Continuous Synthesizer Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Intavis AG Automatic Peptide Continuous Synthesizer Product Portfolio
6.12.5 Intavis AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automatic Peptide Continuous Synthesizer Industry Chain Analysis
7.2 Automatic Peptide Continuous Synthesizer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automatic Peptide Continuous Synthesizer Production Mode & Process
7.4 Automatic Peptide Continuous Synthesizer Sales and Marketing
7.4.1 Automatic Peptide Continuous Synthesizer Sales Channels
7.4.2 Automatic Peptide Continuous Synthesizer Distributors
7.5 Automatic Peptide Continuous Synthesizer Customers
8 Automatic Peptide Continuous Synthesizer Market Dynamics
8.1 Automatic Peptide Continuous Synthesizer Industry Trends
8.2 Automatic Peptide Continuous Synthesizer Market Drivers
8.3 Automatic Peptide Continuous Synthesizer Market Challenges
8.4 Automatic Peptide Continuous Synthesizer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Automatic Peptide Continuous Synthesizer was estimated to be worth US$ 78.74 million in 2025 and is projected to reach US$ 94 million, growing at a CAGR of 2.6% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 136
USD 3950.00
(Single User License)
The global Automatic Peptide Continuous Synthesizer market was valued at US$ 78.74 million in 2025 and is anticipated to reach US$ 94 million by 2032, at a CAGR of 2.6% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 120
USD 2900.00
(Single User License)
The global Automatic Peptide Continuous Synthesizer market size was US$ 76.9 million in 2024 and is forecast to a readjusted size of US$ 91.9 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 97
USD 4250.00
(Single User License)
The global Automatic Peptide Continuous Synthesizer market is projected to grow from US$ 76.9 million in 2024 to US$ 91.9 million by 2031, at a CAGR of 2.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 159
USD 4900.00
(Single User License)
The global market for Automatic Peptide Continuous Synthesizer was estimated to be worth US$ 76.9 million in 2024 and is forecast to a readjusted size of US$ 91.9 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 123
USD 3950.00
(Single User License)
The global market for Automatic Peptide Continuous Synthesizer was valued at US$ 76.9 million in the year 2024 and is projected to reach a revised size of US$ 91.9 million by 2031, growing at a CAGR of 2.6% during the forecast period.
Published Date: 2025-01-13
Pages: 95
USD 2900.00
(Single User License)
The global market for Automatic Peptide Continuous Synthesizer was estimated to be worth US$ 78.74 million in 2025 and is projected to reach US$ 94 million, growing at a CAGR of 2.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 136
The global Automatic Peptide Continuous Synthesizer market was valued at US$ 78.74 million in 2025 and is anticipated to reach US$ 94 million by 2032, at a CAGR of 2.6% from 2026 to 2032.
Published: 2026-04-17
Pages: 120
The global Automatic Peptide Continuous Synthesizer market size was US$ 76.9 million in 2024 and is forecast to a readjusted size of US$ 91.9 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 97
The global Automatic Peptide Continuous Synthesizer market is projected to grow from US$ 76.9 million in 2024 to US$ 91.9 million by 2031, at a CAGR of 2.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 159
The global market for Automatic Peptide Continuous Synthesizer was estimated to be worth US$ 76.9 million in 2024 and is forecast to a readjusted size of US$ 91.9 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 123
The global market for Automatic Peptide Continuous Synthesizer was valued at US$ 76.9 million in the year 2024 and is projected to reach a revised size of US$ 91.9 million by 2031, growing at a CAGR of 2.6% during the forecast period.
Published: 2025-01-13
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now